RhoA Activators represents a diverse group of molecules that play a crucial role in regulating cellular processes by modulating the activity of RhoA, a small GTPase protein. RhoA, a member of the Rho family of GTPases, is a central player in the intricate web of intracellular signaling pathways that govern cell morphology, cytoskeletal dynamics, and cell migration. RhoA, in its active GTP-bound form, exerts its influence by interacting with downstream effectors, most notably Rho-associated protein kinase (ROCK) and various formin proteins. These interactions trigger a cascade of events that lead to actin cytoskeleton reorganization, cell contraction, and changes in cell shape. Members of the RhoA Activators class can be grouped into several categories based on their mechanisms of action. Some compounds, such as Epinephrine and Angiotensin II, activate RhoA by binding to specific cell surface receptors, initiating intracellular signaling cascades that ultimately lead to RhoA activation. Others, like Fasudil and Y-27632, function as inhibitors of RhoA kinase, preventing the phosphorylation and inactivation of RhoA and thereby maintaining it in its active state.
Additionally, compounds like Lysophosphatidic Acid (LPA) can directly enhance RhoA gene transcription by binding to their respective receptors on the cell membrane, thus promoting the synthesis of RhoA proteins. Thrombin and Lipopolysaccharide (LPS), on the other hand, activate RhoA through protease-activated and Toll-like receptors, respectively, initiating the transcriptional activation of RhoA. These RhoA Activators, through their various mechanisms of action, act as molecular switches, finely tuning the activity of RhoA and subsequently impacting fundamental cellular processes like cell adhesion, migration, and contraction. Understanding the intricate ways in which these compounds modulate RhoA provides valuable insights into the regulatory mechanisms governing cell behavior and has implications in various fields of cellular and molecular biology, including studies of cytoskeletal dynamics, cell motility, and tissue development.
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | ¥1467.00 ¥3046.00 | 37 | |
SAHA 是一种组蛋白去乙酰化酶(HDAC)抑制剂,可影响组蛋白的乙酰化状态。通过抑制 HDAC,SAHA 增加了组蛋白乙酰化,导致染色质结构开放和基因表达模式改变。染色质可及性的这种变化会间接影响作为 PRC1 一部分的 RING1 的活性。 | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | ¥3159.00 | 4 | |
5-Azacytidine 是一种 DNA 甲基转移酶抑制剂,可影响 DNA 甲基化模式。通过抑制 DNA 甲基转移酶,5-氮杂胞苷会导致 DNA 低甲基化,从而间接影响基因表达和染色质结构。这些表观遗传变化会影响 RING1 在 PRC1 中的活性。 |